Investors

Investors

The RooLife Group provides fully-integrated eCommerce, digital marketing and customer acquisition services, Therefore, driving online sales for its clients – particularly for China-integrated sales strategies – powered by the RooLife Group hyper-personalisation Artificial Intelligence System.

Interactive Chart

ASX Announcements

31/07/2020 Quarterly Activity and Cash flow Reports
10/07/2020 RLG and AFT Launch Online New Zealand Health Store in China
08/07/2020 Trading Halt
28/05/2020 SLG Brands appoints RooLife to sell COLAB Shampoo in China
07/05/2020 Media Interview - RooLife Quarterly Overview
30/04/2020 Quarterly Activities Report and Appendix 4C
20/04/2020 RooLife Appointed Alipay Marketing Partner
09/04/2020 RooLife Market Update
06/04/2020 RooLife & AFT Pharmaceuticals - China Update
02/04/2020 Trading Halt
02/04/2020 Pause in Trading
10/03/2020 Notice Under Section 708A(5)(e) of the Corporations Act 2001
10/03/2020 Appendix 3Y x 2
10/03/2020 Appendix 2A
10/03/2020 Appendix 3G
10/03/2020 RLG to sell Nuria Beauty in China for Small World Brands
06/03/2020 Results of Meeting
05/03/2020 Appendix 3B
02/03/2020 Australia and China Digital Marketing and e-Commerce Update
25/02/2020 Appendix 4D and Half Yearly Financial Statements
03/02/2020 Notice of General Meeting/Proxy Form
03/02/2020 Initial Director's Interest Notice
03/02/2020 Final Director's Interest Notice
03/02/2020 RLG Board Changes, Director Resignation and Appointment
31/01/2020 Boardroom Media Interview - December Quarter Review
17/12/2019 Notice Under Section 708A(5)(e) of the Corporations Act 2001
17/12/2019 Appendix 3B
11/12/2019 Additional Funds Raised Through Placement
10/12/2019 Placement Completed Successfully Raising $1.5m
09/12/2019 Notice Under Section 708A(5)(e) of the Corporations Act 2001
06/12/2019 Trading Halt
06/12/2019 Forthcoming Release of Voluntary Escrowed Securities
04/12/2019 Appendix 3B
04/12/2019 Partnership with WMall, new China Diagou e-Commerce Platform
04/12/2019 OpenDNA renamed RooLife Group Ltd and QBID Completion
02/12/2019 Results of Meeting
28/11/2019 Acquisition of China e-Commerce Business QBID
31/10/2019 Quarterly Activities and Cash Flow Reports
28/10/2019 Notice of Annual General Meeting/Proxy Form
21/10/2019 TechKnow Invest Conference Presentation
16/10/2019 Notice under Section 708A(5)(e) of the Corporations Act 2001
16/10/2019 Completion of Capital Raising and Appendix 3B
14/10/2019 Response to ASX aware query
14/10/2019 Trading Halt
14/10/2019 Pause in Trading
14/10/2019 OPN Appointed Digital Partner to drive Brand for NBCF
16/09/2019 OPN Partners with Lobster Shack and Agrees $500k Placement
16/09/2019 OPN to Acquire China e-Commerce Business QBID
12/09/2019 Trading Halt
09/09/2019 Change of Director interest Notice x 2
27/12/2018 Notice Under Sec 708A(5)(e) of the Corporations Act 2001
24/12/2018 Change of Director's Interest Notice
24/12/2018 Initial Director's Interest Notice
24/12/2018 Appendix 3B
21/12/2018 Completion of Acquisition and Board and Management Changes
17/12/2018 Notice Under Sec 708A(5)(e) of the Corporations Act 2001
12/12/2018 Completion of Tranche 2 Placement and Appendix 3B
12/12/2018 Change of Director's Interest Notice x2
26/11/2018 Investor Presentation
23/11/2018 Results of Meeting
19/11/2018 Appendix 3B
02/11/2018 Forthcoming Release of Restricted Securities
31/10/2018 Appendix 4C - quarterly
23/10/2018 Notice of Annual General Meeting
01/10/2018 Notice under Section 708A(5)(e) of the Corporations Act 2001
28/09/2018 Completion of Tranche 1 of Placement and Appendix 3B
20/09/2018 Full Year Stat Accounts and Annual Report to Shareholders
20/09/2018 Appendix 4G
20/09/2018 Corporate Governance Statement
12/09/2018 ODA: Divestiture and China Mobile Debt Updates
12/09/2018 OPN Signs Binding Acquisition Agreement and $2.5m Placement
10/09/2018 Trading Halt
29/08/2018 Preliminary Final Report
31/07/2018 Appendix 4C and Quarterly Update
05/06/2018 Corporate Governance Statement
30/11/2017 Final Director's Interest Notice
30/11/2017 Results of Meeting
30/11/2017 AGM Presentation to Shareholders
22/11/2017 OpenDNA to Power Boardroom.Media
17/11/2017 TMT Analytics Research Report
01/11/2017 Appendix 4C - quarterly and Update
27/10/2017 Notice of Annual General Meeting
05/10/2017 OPN signs Master Services Agreement with Expert System
03/10/2017 MOU with innovative gaming community creator Uproar
29/09/2017 Appendix 4G
29/09/2017 Full Year Statutory Accounts & Annual Report to Shareholders
28/09/2017 OPN signs MOU with International Publisher Epoch Times
26/09/2017 MOU with leading virtual world company Gaia Interactive
18/09/2017 Operational Update
13/09/2017 OPN Launches Business-Ready Data Visualization Tools
08/09/2017 Appendix 3B
04/09/2017 Investor Presentation
31/08/2017 Appendix 4E - Preliminary Final Report
23/08/2017 Forthcoming Release of Restricted Securities
17/08/2017 TMT Analytics Research Report
10/08/2017 Binding MOU With Leading BI Platform Provider Looker
28/07/2017 Appendix 4C and Quarterly Update
25/07/2017 IRIS tool to significantly enhance OpenDNA AI System
17/07/2017 OpenDNA to create APP for Endeavour Drinks Group
13/07/2017 Trading Halt
23/12/2016 MoU signed with MediaFuse
07/12/2016 Q&A Session with CEO Jay Shah
18/11/2016 OpenDNA Strengthens International Sales Team
16/11/2016 Personalisation Technology Company OpenDNA Lists on the ASX
15/11/2016 Initial Director's Interest Notices
15/11/2016 Initial Substantial Holder Notices
15/11/2016 Full terms of Performance Shares
15/11/2016 Capital structure and restricted securities schedule
15/11/2016 Securities trading policy
15/11/2016 Terms of employee share option plan
15/11/2016 Updated statement of commitments
15/11/2016 Updated pro-forma statement of financial position
15/11/2016 Constitution
15/11/2016 Appendix 1A and Information Form and Checklist
15/11/2016 Top 20 Holders
15/11/2016 Distribution Schedule
15/11/2016 Pre-Quotation Disclosure
15/11/2016 ASX Circular - Admission and Commencement of Quotation
15/11/2016 Admission to the Official List
07/10/2016 Prospectus

Ready to find out more?

Set up a 30 minute consultation now.

Book A Free Consultation